第3天前异常卵裂不影响实现完全囊胚化的胚胎的活产和新生儿结局:一项回顾性队列研究
该回顾性队列研究纳入2017年1月至2022年6月澳大利亚Fertility North的1562个自体体外受精周期,分析6019个囊胚培养胚胎中664个单囊胚冻融移植。异常卵裂(ABNCL)降低完全囊胚化率,但一旦实现完全囊胚化,活产率、胎龄和出生体重与无ABNCL囊胚无显著差异。
要点
- 直接卵裂、反向卵裂、4细胞期接触点<6及混合ABNCL的完全囊胚化率均低于无ABNCL者(P<0.01)。
- 单囊胚冻融移植后,ABNCL组与无ABNCL组的活产率、胎龄和出生体重无显著差异(P>0.05)。
- 多因素回归校正混杂因素后,上述结局指标仍无差异。
核心结论
- ABNCL与完全囊胚化率降低相关,但一旦实现完全囊胚化,不影响活产率和新生儿结局。
研究设计与样本
- 回顾性队列研究,纳入2017年1月至2022年6月澳大利亚Fertility North的1562个连续自体体外受精周期(母亲年龄35.1±4.7岁)。
- 共6019个胚胎进行囊胚培养,其中664个形成的冻融囊胚纳入单胚胎移植后的活产和新生儿结局分析。
- 新鲜移植于第3天或第5天进行,剩余胚胎培养至第6天后玻璃化冷冻。
主要发现
- 直接卵裂、反向卵裂、4细胞期接触点<6和混合(≥2种)ABNCL的完全囊胚化率分别为19.5%、41.7%、58.8%和26.4%,均低于无ABNCL者的67.2%(P<0.01)。
- 按第3天前受影响的卵裂球占所有卵裂球比例分层,完全囊胚化率随比例增加而下降:0受影响为66.2%,0.25为47.0%,0.5为27.4%,0.75为14.5%,全部受影响为7.7%(P<0.01)。
- 单囊胚冻融移植后,直接卵裂、反向卵裂、4细胞期接触点<6和无ABNCL组的活产率分别为25.9%、33.0%、36.0%和30.8%,无显著差异(P>0.05)。
- 上述四组的胎龄分别为38.7±1.6、38.5±1.2、38.3±3.5和38.5±1.8周,出生体重分别为3343.0±649.1、3378.2±538.4、3352.6±841.3和3313.9±509.6 g,均无显著差异(P>0.05)。
- 多因素回归(logistic或线性回归)校正潜在混杂因素后,上述指标仍无差异。
临床怎么用
- 作者认为,ABNCL囊胚令人安心的活产和新生儿结局提示达到囊胚阶段的胚胎可能存在自我修正机制,为临床实践和患者咨询提供了有价值的指导。
局限性
- 研究为回顾性性质,无法控制所有已知或未知的混杂因素。
- 数据集中的胚胎为新鲜移植选择后的剩余胚胎,可能不能代表一般胚胎人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do embryos displaying abnormal cleavage (ABNCL) up to Day 3 have compromised live birth rates and neonatal outcomes if full blastulation has been achieved prior to transfer? SUMMARY ANSWER: ABNCL is associated with reduced full blastulation rates but does not impact live birth rates and neonatal outcomes once full blastulation has been achieved. WHAT IS KNOWN ALREADY?: It is widely accepted that ABNCL is associated with reduced implantation rates of embryos when transferred at the cleavage stage. However, evidence is scarce in the literature reporting birth outcomes from blastocysts arising from ABNCL embryos, likely because they are ranked low priority for transfer. STUDY DESIGN, SIZE, DURATION: This retrospective cohort study included 1562 consecutive autologous in vitro fertilization cycles (maternal age 35.1 ± 4.7 years) performed at Fertility North, Australia between January 2017 and June 2022. Fresh transfers were performed on Day 3 or 5, with remaining embryos cultured up to Day 6 before vitrification. A total of 6019 embryos were subject to blastocyst culture, and a subset of 664 resulting frozen blastocysts was included for live birth and neonatal outcome analyses following single transfers. PARTICIPANTS/MATERIALS, SETTING, METHODS: ABNCL events were annotated from the first mitotic division up to Day 3, including direct cleavage (DC), reverse cleavage (RC) and <6 intercellular contact points at the 4-cell stage (<6ICCP). For DC and RC in combination, the ratios of affected blastomeres over the total number of all blastomeres up to Day 3 were also recorded. All pregnancies were followed up until birth with gestational age, birthweight, and sex of the baby being recorded. MAIN RESULTS AND THE ROLE OF CHANCE: Full blastulation rates for embryos showing DC (19.5%), RC (41.7%), <6ICCP (58.8%), and mixed (≥2) ABNCL types (26.4%) were lower than the rates for those without ABNCL (67.2%, P < 0.01 respectively). Subgroup analysis showed declining full blastulation rates with increasing ratios of combined DC/RC affected blastomeres over all blastomeres up to the 8-cell stage (66.2% when 0 affected, 47.0% when 0.25 affected, 27.4% when 0.5 affected, 14.5% when 0.75 affected, and 7.7% when all affected, P < 0.01). However, once full blastulation had been achieved, no difference was detected between DC, RC, <6ICCP, and no ABNCL blastocysts following single frozen transfers in subsequent live birth rates (25.9%, 33.0%, 36.0% versus 30.8%, P > 0.05, respectively), gestational age (38.7 ± 1.6, 38.5 ± 1.2, 38.3 ± 3.5 versus 38.5 ± 1.8 weeks, P > 0.05, respectively) and birthweight (3343.0 ± 649.1, 3378.2 ± 538.4, 3352.6 ± 841.3 versus 3313.9 ± 509.6 g, P > 0.05, respectively). Multiple regression (logistic or linear as appropriate) confirmed no differences in all of the above measures after accounting for potential confounders. LIMITATIONS, REASONS FOR CAUTION: Our study is limited by its retrospective nature, making it impossible to control every known or unknown confounder. Embryos in our dataset, being surplus after selection for fresh transfer, may not represent the general embryo population. WIDER IMPLICATIONS OF THE FINDINGS: Our findings highlight the incremental impact of ABNCL, depending on the ratio of affected blastomeres up to Day 3, on subsequent full blastulation. The reassuring live birth and neonatal outcomes of ABNCL blastocysts imply a potential self-correction mechanism among those embryos reaching the blastocyst stage, which provides valuable guidance for clinical practice and patient counseling. STUDY FUNDING/COMPETTING INTEREST(S): This research is supported by an Australian Government Research Training Program (RTP) Scholarship. All authors report no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Lee T, Peirce K, Natalwala J, et al. Abnormal cleavage up to Day 3 does not compromise live birth and neonatal outcomes of embryos that have achieved full blastulation: a retrospective cohort study. Hum Reprod. 2024. PMID: 38553025. doi:10.1093/humrep/deae062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。